| Literature DB >> 29030767 |
Luigi Zuliani1, Marco Zoccarato2, Matteo Gastaldi3, Raffaele Iorio4, Amelia Evoli4, Tiziana Biagioli5, Silvia Casagrande5, Elena Bazzigaluppi6, Raffaella Fazio6, Claudia Giannotta7, Eduardo Nobile-Orazio7, Francesca Andreetta8, Ornella Simoncini8, Gianna Costa9, Sara Mariotto10, Sergio Ferrari10, Elisabetta Galloni11, Michela Marcon11, Diego Franciotta12, Bruno Giometto2.
Abstract
This document presents the guidelines for testing antibodies against neuronal surface antigens that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on autoimmune encephalitis associated with antibodies against neuronal surface antigens, indications and limits of testing for such antibodies, instructions for result interpretation, and an agreed laboratory protocol (Appendix A) are reported for the communicative community of neurologists and clinical pathologists.Entities:
Keywords: Anti-N-methyl-D-aspartate receptor (NMDA-R) antibodies; Anti-contactin-associated protein-like 2 (CASPR2) antibodies; Anti-leucine-rich glioma inactivated 1 (LGI1) antibodies; Cell-based assays; Laboratory diagnostics
Mesh:
Substances:
Year: 2017 PMID: 29030767 DOI: 10.1007/s10072-017-3032-4
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307